109 related articles for article (PubMed ID: 37709374)
21. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
22. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
23. Identification of hub genes and pathways in lung metastatic colorectal cancer.
Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
[TBL] [Abstract][Full Text] [Related]
24. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
[TBL] [Abstract][Full Text] [Related]
25. Circadian clock as a possible control point in colorectal cancer progression (Review).
Rao X; Lin L
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263655
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms investigation for liver metastasis of colorectal cancer by combined bioinformatic gene expression profile analysis.
Wu QQ; Wang XY; Wu WX; Chen YX; Wang J; Zhang X; Qian Y; Du SS; Sun J; Zeng ZC
Cancer Treat Res Commun; 2023; 35():100694. PubMed ID: 36868002
[TBL] [Abstract][Full Text] [Related]
27. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
[TBL] [Abstract][Full Text] [Related]
28. Identification and meta-analysis of copy number variation-driven circadian clock genes for colorectal cancer.
Yuan W; Liu L; Wei C; Li X; Sun D; Dai C; Li S; Peng S; Jiang L
Oncol Lett; 2019 Nov; 18(5):4816-4824. PubMed ID: 31611992
[TBL] [Abstract][Full Text] [Related]
29. Integrated analysis of intestinal microbiota and host gene expression in colorectal cancer patients.
Chen Y; Si H; Bao B; Li S; Teng D; Yan Y; Hu S; Xu Y; Du X
J Med Microbiol; 2022 Sep; 71(9):. PubMed ID: 36136380
[No Abstract] [Full Text] [Related]
30. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
Liang Y; Zhang C; Ma MH; Dai DQ
World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
[TBL] [Abstract][Full Text] [Related]
31. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
32. The key genes underlying pathophysiology association between the type 2-diabetic and colorectal cancer.
Peng WF; Bai F; Shao K; Shen LS; Li HH; Huang S
J Cell Physiol; 2018 Nov; 233(11):8551-8557. PubMed ID: 29319171
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics-based identification of key genes and pathways associated with colorectal cancer diagnosis, treatment, and prognosis.
Wang C; Zhang L
Medicine (Baltimore); 2022 Sep; 101(37):e30619. PubMed ID: 36123948
[TBL] [Abstract][Full Text] [Related]
34. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
35. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
[TBL] [Abstract][Full Text] [Related]
36. Identification of key genes in colorectal cancer using random walk with restart.
Cui X; Shen K; Xie Z; Liu T; Zhang H
Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
[TBL] [Abstract][Full Text] [Related]
37. The role of circadian genes in the pathogenesis of colorectal cancer.
Razi Soofiyani S; Ahangari H; Soleimanian A; Babaei G; Ghasemnejad T; Safavi SE; Eyvazi S; Tarhriz V
Gene; 2021 Dec; 804():145894. PubMed ID: 34418469
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of RNA-binding proteins in human colorectal cancer.
Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
[TBL] [Abstract][Full Text] [Related]
39. The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer.
Slattery ML; Mullany LE; Sakoda LC; Wolff RK; Stevens JR; Samowitz WS; Herrick JS
Mol Carcinog; 2018 Feb; 57(2):243-261. PubMed ID: 29068474
[TBL] [Abstract][Full Text] [Related]
40. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
